Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Novartis India has informed that the Company is issuing a duplicate share certificate to the shareholders as detailed in the attachment, as per the information received from the Company's Registrar and Share Transfer Agent on January 13, 2022. Further, as per the information received from the Company's Registrar and Share Transfer Agent on January 15, 2022, the shareholder has reported the loss of share certificate as detailed in the attachment.
The above information is a part of company’s filings submitted to BSE.
